29 - Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients

Fabio Ciceri,Maria Teresa Lupo Stanghellini,Raffaella Greco,Giacomo Oliveira,Lutz Uharek,Donald Bunjes,Wolfgang Bethge,Chiara Bonini,Myriam Labopin,Evangelia Yannaki,Mohamad Mohty,Arnon Nagler,Andrew L Pecora,Claudio Bordignon,Attilio Bondanza,Scialini Colombi,Dietger Niederwieser,Eva M Weissinger ,A Lambiase ,Michael Stadler ,Michèle L Donato ,John F Dipersio ,Eduardo Olavarría

doi:10.1016/j.bbmt.2017.01.017

Abstract

29 - Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients

Full Text